Mayne Pharma Group Limited

ASX MYX.AX

Mayne Pharma Group Limited Gross Profit Margin for the year ending June 30, 2024: 56.30%

Mayne Pharma Group Limited Gross Profit Margin is 56.30% for the year ending June 30, 2024, a 285.12% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Mayne Pharma Group Limited Gross Profit Margin for the year ending June 30, 2023 was 14.62%, a -3.25% change year over year.
Mayne Pharma Group Limited Gross Profit Margin for the year ending June 30, 2022 was 15.11%, a -52.32% change year over year.
Mayne Pharma Group Limited Gross Profit Margin for the year ending June 30, 2021 was 31.69%, a 2.76% change year over year.
Mayne Pharma Group Limited Gross Profit Margin for the year ending June 30, 2020 was 30.84%, a -22.52% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

ASX: MYX.AX

Mayne Pharma Group Limited

CEO	Mr. Shawn Patrick O'Brien B.Sc
IPO Date	June 29, 2007
Location	Australia
Headquarters	1538 Main North Road
Employees	850
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies Specialty Retail

Description

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Key trends

Past 5 years